Category: Speeches

  • Nick Clegg – 2016 Parliamentary Question to the Department of Health

    Nick Clegg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nick Clegg on 2016-03-17.

    To ask the Secretary of State for Health, what estimate he has made of the difference in cost to the public purse of people using medicinal cannabis rather than prescription drugs in each of the last three years; and if he will make a statement.

    George Freeman

    We have made no such estimates.

    Herbal cannabis is not licensed as a medicine and, under section 7(4) of the Misuse of Drugs Act 1971, a pharmacist would need to obtain a licence from the Home Office if they were to dispense cannabis.

  • Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Tonge on 2016-04-25.

    To ask Her Majesty’s Government what representations they have made to the government of Israel concerning its possession of nuclear weapons and the admission of inspectors from the International Atomic Energy Agency.

    Baroness Anelay of St Johns

    We have regular discussions with the Government of Israel on a wide range of nuclear-related issues. Israel has not declared a nuclear weapons programme.

    Israel does have a facility-specific safeguards agreement in place with the International Atomic Energy Agency (IAEA). The agreement applies to a single facility in Israel, which is the Soreq Nuclear Research Reactor. The facility is inspected by the IAEA to ensure that it is not used for weapons purposes. We continue to call on Israel to upgrade this arrangement to a full scope Comprehensive Safeguards agreement with the IAEA.

  • Earl Baldwin of Bewdley – 2016 Parliamentary Question to the Department of Health

    Earl Baldwin of Bewdley – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Earl Baldwin of Bewdley on 2016-06-06.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 12 October 2015 (HL1940), what assessment they have made of the reasons why systematic scientific reviews, such as Cochrane reviews, adopt specific and relatively narrow criteria”.”

    Lord Prior of Brampton

    The 2015 Cochrane review Water fluoridation for the prevention of dental caries was an update of a Cochrane review first completed in 2000. A panel of experts agreed the search criteria in the original review, and the update kept these largely unchanged.

    The National Institute for Health Research is currently funding an evaluation of a water fluoridation scheme in Cumbria. This started in 2013 and the final report is expected to be published in 2021. Findings from the evaluation will be available for consideration in any subsequent systematic reviews relating to water fluoridation.

  • Jonathan Ashworth – 2016 Parliamentary Question to the Department for Business, Energy and Industrial Strategy

    Jonathan Ashworth – 2016 Parliamentary Question to the Department for Business, Energy and Industrial Strategy

    The below Parliamentary question was asked by Jonathan Ashworth on 2016-07-20.

    To ask the Secretary of State for Business, Energy and Industrial Strategy, which Minister in his Department has responsibility for tacking corruption.

    Margot James

    I am the Minister for Small Business, Consumers and Corporate Responsibility and I lead on competition law. I have a particular focus on ensuring that companies including directors, shareholders and employees achieve high standards of corporate behaviour to ensure that the public has trust in business and recognises their value to society.

    I have specific responsibility for the UK’s register of People with Significant Control. I lead on the Department’s interests in transposing the Fourth Anti Money Laundering Directive. I am also the lead Minister for the Department on taking forward the UK’s commitments agreed at the May anticorruption summit in London.

  • Christopher Chope – 2016 Parliamentary Question to the Department of Health

    Christopher Chope – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Christopher Chope on 2016-10-11.

    To ask the Secretary of State for Health, how many proceedings for debt recovery the NHS has issued in the county court for NHS prescription charges and penalties in the last year for which information is available; how many such proceedings resulted in recovery of the outstanding money.

    David Mowat

    The number of National Health Service prescription charge penalty charge notices issued between September 2015 and August 2016, which is the most recent 12-month period for which we have complete data, was 780,953. Where no response was received to the initial penalty charge notice a follow up surcharge letter was issued to the patient. For the same period a total of 333,508 surcharge letters were issued.

    The value of the recovered prescription income in this period was £2,556,941, and the value of the income from penalty charges and surcharges was £8,678,911 and £745,830, respectively.

    Since taking over the administration of the Prescription Exemption Checking Service in September 2014, the NHS Business Services Authority has not issued any court proceedings for debt recovery in relation to NHS prescription charges and penalties.

  • Baroness Lister of Burtersett – 2015 Parliamentary Question to the Department of Health

    Baroness Lister of Burtersett – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Lister of Burtersett on 2015-11-18.

    To ask Her Majesty’s Government what consideration they have given to the viability of (1) the care home sector, and (2) the private home care provider sector, in the light of local government expenditure restraint and the implementation of the National Living Wage.

    Lord Prior of Brampton

    The Government has engaged with the care sector, including care providers, to understand the impact on the market arising from amongst other things, local authority commissioning behaviour and the introduction of the National Living Wage. This has included a number of deep dive sessions held with both care home businesses and providers of home care services.

    As part of its spending plans for the next four years the Government is giving local authorities access to £3.5 billion of new support for adult social care by 2019/20. Local authorities will be able to introduce a new Social Care Precept, allowing them to increase council tax by 2% above the existing threshold. The Government estimates this could raise nearly £2 billion a year for adult social care by 2019/20.

    Councils will need to increase the price they pay for care to cover costs for care providers such as the National Living Wage. To support this, the Social Care Precept puts money raising powers into the hands of local authorities which are best placed to target resources based on their understanding of their local care market.

  • Jim Shannon – 2016 Parliamentary Question to the Home Office

    Jim Shannon – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Jim Shannon on 2016-01-05.

    To ask the Secretary of State for the Home Department, what discussions she has had with the British Association for Shooting and Conservation and the Countryside Alliance on the banning of hand-guns and pistols.

    Mike Penning

    Home Office Ministers and officials have meetings with a wide variety of international partners, as well as organisations and individuals in the public and private sectors, as part of the process of policy development and delivery. Details of these meetings are published on the Cabinet Office website on a quarterly basis at: www.gov.uk/government/organisations/cabinet-office.

  • Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Louise Haigh on 2016-01-29.

    To ask Mr Chancellor of the Exchequer, whether Concentrix has met its targets set in its service level agreement.

    Mr David Gauke

    In HM Revenue and Customs’ contract with Concentrix there are three Key Performance Indicators. These cover post and telephony expectations, and all three are currently being met. There is also one Quality Performance Indicator, where the most recent indicative result is 95.2% against an expectation of 97%.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-02-24.

    To ask the Secretary of State for Health, what assessment he has made of in which type of healthcare there is greatest geographical disparity of treatment (a) availability, (b) choice and (c) outcomes across England.

    Jane Ellison

    No such assessment has been made. However, the Right Care programme actively uses variation between clinical commissioning groups to help identify those diseases or conditions that have the potential for greatest improvement. Indicators used include prevalence, treatment and outcomes.

    The NHS Atlas of Variation, Commissioning for Value Packs and indicators in the National Health Service Outcomes Framework and Public Health Outcomes Framework provide publicly accessible resources to compare geographical areas and highlight health inequalities and other variation across a wide variety of indicators.

  • Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ben Bradshaw on 2016-03-17.

    To ask the Secretary of State for Health, what estimate he has made of the potential change in the prevalence of genital warts following the award of the contract for supply of human papillomavirus vaccine to the bivalent vaccine.

    Jane Ellison

    The human papilloma virus (HPV) vaccination programme was introduced in 2008, when the bivalent vaccine Cervarix was administered. From September 2012, following a competitive tender exercise, the quadrivalent vaccine Gardasil was introduced.

    Both protect against the two strains of HPV (HPV16 and HPV18) that cause 70% of cervical cancer. Gardasil also protects against the two HPV types that cause around 90% of all genital warts (HPV6 and HPV11).

    A decrease in genital warts was not anticipated for the bivalent HPV vaccine, Cervarix. An estimate of the change in prevalence of genital warts has not been carried out.

    However, rates of genital warts in genito-urinary medicine (GUM) clinics have declined significantly amongst the population vaccinated. Data reported to Public Health England from GUM clinics shows a reduction in rates of genital warts diagnoses at GUM clinics between 2009 and 2014 of 30.6% in 15-19 year-old females and 25.4% amongst same age heterosexual males.